Skip to main content
mediabuyer
← Spy index

Landing-page host dossier

Ads pointing to precisionmedicineonline.com

27 creatives · 3 advertisers · 1 network

Total ads

27

Advertisers

3

First seen

Apr 14

Last seen

May 11

Networks

mediabuyer.site indexes 27 native ad creatives whose landing page resolves to precisionmedicineonline.com. Those creatives are produced by 3 distinct advertisers and run across Outbrain (27). The geographic footprint includes QA (22), South Korea (15), Taiwan (14), Finland (10), Australia (5), Singapore (4), Canada (1). Top verticals on this host: health, general. Average creative longevity for this host is 12 days; the longest-running ad has been live for 26 days. The first ad pointing at precisionmedicineonline.com entered our index on Apr 14; the most recent on May 11. Use the gallery below to inspect every active creative, the headline patterns advertisers are testing, and the related landing pages that share the same advertiser base.

Top creatives

ranked by longevity

Real-World Data Show Most Bladder Cancer Patients Getting Biomarker Testing in Community Network
mediabuyer
IHC Reference Standards Aim to Help Labs Measure Low HER2 Expression to Guide Enhertu Treatment
mediabuyer
Study Shows Feasibility of Offering MSK-IMPACT Test Internationally for Pediatric Cancer
mediabuyer
OutbrainOther
Study Shows Feasibility of Offering MSK-IMPACT Test Internationally for Pediatric Cancer
Precision Medicine Online | Sponsored@precision
🇦🇺AU22d+3
precisionmedicineonline.com
Visit
FDA Rule Dead and Buried, Oncologists Navigate Complex Lab-Developed Test Landscape
mediabuyer
OutbrainOther
FDA Rule Dead and Buried, Oncologists Navigate Complex Lab-Developed Test Landscape
Promoted by Precision Medicine Online@promoted
🇫🇮FI22d+1
precisionmedicineonline.com
Visit
MRD, MCED Most Promising Cancer Dx Technologies, According to Labcorp Oncologist Survey
mediabuyer
OutbrainOther
MRD, MCED Most Promising Cancer Dx Technologies, According to Labcorp Oncologist Survey
Precision Medicine Online | Sponsored@precision
🇫🇮FI19d+3
precisionmedicineonline.com
Visit
Mercy Bio Planning Limited Launch of Ovarian Cancer Screening Test in Q1 2026
mediabuyer
OutbrainE-commerce
Mercy Bio Planning Limited Launch of Ovarian Cancer Screening Test in Q1 2026
Precision Medicine Online | Sponsored@precision
🇦🇺AU16d+2
precisionmedicineonline.com
Visit
Study Shows Feasibility of Offering MSK-IMPACT Test Internationally for Pediatric Cancer
mediabuyer
OutbrainOther
Study Shows Feasibility of Offering MSK-IMPACT Test Internationally for Pediatric Cancer
Precision Medicine Online | Sponsored@precision
🇫🇮FI15d+3
precisionmedicineonline.com
Visit
Four-Biomarker Blood Test Could Improve Early Pancreatic Cancer Detection
mediabuyer
OutbrainOther
Four-Biomarker Blood Test Could Improve Early Pancreatic Cancer Detection
Precision Medicine Online | Sponsored@precision
🇦🇺AU14d+3
precisionmedicineonline.com
Visit
Mercy Bio Planning Limited Launch of Ovarian Cancer Screening Test in Q1 2026
mediabuyer
OutbrainE-commerce
Mercy Bio Planning Limited Launch of Ovarian Cancer Screening Test in Q1 2026
Precision Medicine Online@precision
🇰🇷KR11d+1
precisionmedicineonline.com
Visit

Sample headlines

  • Study Shows Feasibility of Offering MSK-IMPACT Test Internationally for Pediatric Cancer×4
  • Real-World Data Show Most Bladder Cancer Patients Getting Biomarker Testing in Community Network×3
  • Mercy Bio Planning Limited Launch of Ovarian Cancer Screening Test in Q1 2026×3
  • ASCO: Razor Genomics Test Shows Promise for Chemotherapy Selection in High-Risk Lung Cancer Patients×2
  • ASCO Data on Personalis Assay Suggests Role for ctDNA MRD Testing in Cervical Cancer×2
  • Steroids May Obscure Predictive Power of Circulating Biomarkers in Lung Cancer Patients, Study Finds×2
  • IHC Reference Standards Aim to Help Labs Measure Low HER2 Expression to Guide Enhertu Treatment×1
  • FDA Rule Dead and Buried, Oncologists Navigate Complex Lab-Developed Test Landscape×1
  • MRD, MCED Most Promising Cancer Dx Technologies, According to Labcorp Oncologist Survey×1
  • Clinicians Offering Early Access to Grail's MCED Test Await Full NHS Trial Readout After Endpoint Miss×1
  • Four-Biomarker Blood Test Could Improve Early Pancreatic Cancer Detection×1
  • ctDNA Useful for Deescalating Breast Cancer Treatment in Older Women, U of Pittsburgh Study Finds×1

Top advertisers using precisionmedicineonline.com

Full gallery

every indexed ad

ctDNA Useful for Deescalating Breast Cancer Treatment in Older Women, U of Pittsburgh Study Finds
mediabuyer
ASCO Data on Personalis Assay Suggests Role for ctDNA MRD Testing in Cervical Cancer
mediabuyer
OutbrainOther
ASCO Data on Personalis Assay Suggests Role for ctDNA MRD Testing in Cervical Cancer
Precision Medicine Online | Sponsored@precision
🇫🇮FI10d+1
precisionmedicineonline.com
Visit
Study Shows Feasibility of Offering MSK-IMPACT Test Internationally for Pediatric Cancer
mediabuyer
OutbrainOther
Study Shows Feasibility of Offering MSK-IMPACT Test Internationally for Pediatric Cancer
Precision Medicine Online | Sponsored@precision
🇰🇷KR9d+1
precisionmedicineonline.com
Visit
AI Tools Stumped By HER2-Low Breast Cancer Just Like Pathologists, Study Finds
mediabuyer
OutbrainOther
AI Tools Stumped By HER2-Low Breast Cancer Just Like Pathologists, Study Finds
Precision Medicine Online | Sponsored@precision
🇦🇺AU7d+1
precisionmedicineonline.com
Visit
GeneCentric Presents First Clinical Data for Liquid Biopsy Fragmentomic Technology at AACR
mediabuyer
OutbrainOther
GeneCentric Presents First Clinical Data for Liquid Biopsy Fragmentomic Technology at AACR
Precision Medicine Online | Sponsored@precision
🇰🇷KR6d+2
precisionmedicineonline.com
Visit
Real-World Data Show Most Bladder Cancer Patients Getting Biomarker Testing in Community Network
mediabuyer
Mercy Bio Planning Limited Launch of Ovarian Cancer Screening Test in Q1 2026
mediabuyer
OutbrainE-commerce
Mercy Bio Planning Limited Launch of Ovarian Cancer Screening Test in Q1 2026
Precision Medicine Online | Sponsored@precision
🇫🇮FI4d+1
precisionmedicineonline.com
Visit
DPYD Testing Before Chemo at Atrium Health Saves $37 per Patient, Leads to Fewer Hospitalizations
mediabuyer
OutbrainE-commerce
DPYD Testing Before Chemo at Atrium Health Saves $37 per Patient, Leads to Fewer Hospitalizations
Precision Medicine Online | Sponsored@precision
🇰🇷KR4d+1
precisionmedicineonline.com
Visit
Real-World Data Show Most Bladder Cancer Patients Getting Biomarker Testing in Community Network
mediabuyer